期刊文献+

靶向高迁移率族蛋白1基因的高效RNA干扰序列的筛选

Screening of high effective siRNAs targeting high mobility group box 1 protein gene
原文传递
导出
摘要 目的筛选靶向晚期炎症因子高迁移率族蛋白1(High mobility group box 1 protein,HMGB1)基因的高效RNA干扰(siRNA)序列,并检测其体外生物学效应。方法选择针对HMGB1基因mRNA的3条不同序列,用T7体外转录系统合成3条siRNA,转染RAW264.7细胞,6 h后,加入500 ng/ml脂多糖(Lipopolysaccharide,LPS)分别刺激24、48 h,另设单纯LPS刺激组和只加培养液的对照组。采用RT-PCR检测各组细胞中HMGB1基因mRNA的转录水平,ELISA检测细胞培养上清液中HMGB1的含量。结果体外合成的HMGB1 siRNA1~3经琼脂糖凝胶电泳分析,均可见21 bp的RNA片段;经LPS刺激24和48 h,RAW264.7细胞中HMGB1基因mRMA的转录水平和细胞培养上清液中HMGB1的含量与对照组相比均显著升高,3条HMGB1 siRNA均能抑制细胞中HMGB1基因mRNA的转录水平,并减少细胞培养上清液中HMGB1的含量,其中以HMGB1siRNA1的效果最为明显。结论 LPS可刺激RAW264.7细胞释放大量HMGB1,同时增加细胞中mRNA的转录水平;HMGB1siRNA能有效降低HMGB1蛋白和mRNA水平,有望成为控制晚期炎症发展的新的治疗手段。 Objective To screen the high effective siRNAs targeting the gene encoding high mobility group box protein 1 (HMGB1), a late mediator of inflammation, and determine its biological effect in vitro. Methods Three siRNA sequences specific to HMGB1 mRNA were selected and synthesized by T'] transcription system in vitro. RAW264. 7 cells were divided into five groups. The cells in intervention groups 1, 2 and 3 were transfected with synthesized HMGB1 siRNAs 1 N3 respectively and, 6 h later, stimulated with 500 ng/ml lipopolysaccharide (LPS) for 24 and 48 h, while those in LPS group were untransfected and only stimulated with LPS, and those in control group were only added with medium. The transcription levels of HMGB1 mRNAs in cells of various groups were determined by RT-PCR, while the HMGB1 contents in culture supernatants by ELISA. Results The RNA fragments each at a length of 21 bp were observed on agarose gel electrophoretic profile of synthesized HMGB1 siRNAs 1 N 3. After stimulation with LPS for 24 and 48 h, both the transcription levels of HMGB1 mRNAs and HMGB1 contents in culture supernatants of cells in three intervention groups were significantly higher than those in control group. All the three HMGB1 siRNAs inhibited the transcription of HMGB1 mRNA in cells and decreased the HMGB1 content in cell culture supernatant, of which siRNA1 showed satisfactory effect as compared with siRNA2 and siRNA3. Conclusion LPS stimulated RAW264. 7 cells to release a large quantity of HMGB1 and increased the transcription level of mRNA in the cells. HMGB1 siRNA decreased the protein and mRNA levels of HMGB1, which might provide a new method for controlling the progress of late inflammation.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第4期437-440,共4页 Chinese Journal of Biologicals
关键词 HMGB1蛋白质 RNA干扰 RAW264.7细胞 HMGB1 protein RNA interference RAW264. 7 cells
  • 相关文献

参考文献3

二级参考文献33

  • 1Young BC, Levine R J, Karumanchi SA. Pathogenesis of preeclampsia [J]. Annu Rev Pathol, 2010, 5: 173-192.
  • 2Foidart JM, Schaaps JP, Chantraine F, et al. Dysregulation of anti-angiogenic agents (sFh-1, PIGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer [J]. J Reprod Immunol, 2009, 82 (2): 106-i11.
  • 3Rosemary Siafakas A, Richardson DR. Growth arrest and DNA damage-45 alpha (GADD45alpha) [J]. Int J Biochem Cell Biol, 2009, 41 (5): 986-989.
  • 4Gao M, Guo N, Huang C, et al. Diverse roles of GADD45alpha in stress signaling [J]. Curr Protein Pept Sci, 2009, 10 (4): 388- 394.
  • 5Xiong Y, Liebermann DA, Tront JS, et al. Gadd45α stress signaling regulates sFlt-1 expression in preeclampsia [ J ]. J Cell Physiol, 2009, 220 (3) : 632-639.
  • 6Zerbini LF, Wang Y, Czibere A, et al. NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival [J]. Proc Natl Acad Sci USA, 2004, 101 (37): 13618-13623.
  • 7Gu Y, Lewis DF, Wang Y. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies [J]. J Clin Endocrinol Metab, 2008, 93 ( 1 ): 260-266.
  • 8Venkatesha S, Toporsian M, Lam C. et al. Soluble endoglin contributes to the pathogenesis of preeclampsia [J]. Nat Med, 2006, 12 (6): 642-649.
  • 9Manjunath N, Wu H, Subramanya S, et al. Lentiviral delivery of short hairpin RNAs [J]. Adv Drug Deliv Rev, 2009, 61 (9): 732- 745.
  • 10Bos TJ, De Bruyne E, Heimmn C, et al. In search of the most suitable lentiviral shRNA system [J]. Curr Gene Ther, 2009, 9 (3): 192-211.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部